Literature DB >> 1933603

Is fluoride treatment justified today?

J A Inkovaara1.   

Abstract

Fluoride has been used for the treatment of osteoporosis since 1961, because it increases trabecular bone mass in the spine and may be effective in the treatment of spinal osteoporosis. Fluoride treatment is still controversial because of its side effects, the high rate of non-responders, possible osteomalacic effect on bone, deleterious effects on cortical bone, and especially because of its uncertain effect on fracture rate. At present, fluoride therapy is highly questionable in the prophylaxis and treatment of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933603     DOI: 10.1007/bf02555093

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  12 in total

Review 1.  Fluoride and osteoporosis.

Authors:  C Y Pak
Journal:  Proc Soc Exp Biol Med       Date:  1989-07

Review 2.  Fluoride and osteoporosis.

Authors:  J Franke
Journal:  Ann Chir Gynaecol       Date:  1988

3.  The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride.

Authors:  A B Hodsman; D J Drost
Journal:  J Clin Endocrinol Metab       Date:  1989-11       Impact factor: 5.958

4.  Prophylactic fluoride treatment and aged bones.

Authors:  J Inkovaara; R Heikinheimo; K Jarvinen; U Kasurinen; H Hanhijarvi; E Iisalo
Journal:  Br Med J       Date:  1975-07-12

5.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

Authors:  B L Riggs; S F Hodgson; W M O'Fallon; E Y Chao; H W Wahner; J M Muhs; S L Cedel; L J Melton
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

6.  Long-term fluoride therapy of postmenopausal osteoporosis.

Authors:  M A Dambacher; J Ittner; P Ruegsegger
Journal:  Bone       Date:  1986       Impact factor: 4.398

7.  The effect of fluoride on bone histology in postmenopausal osteoporosis depends on adequate fluoride absorption and retention.

Authors:  F H Budden; T A Bayley; J E Harrison; R G Josse; T M Murray; W C Sturtridge; R Kandel; R Vieth; A L Strauss; S Goodwin
Journal:  J Bone Miner Res       Date:  1988-04       Impact factor: 6.741

8.  Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis.

Authors:  N Mamelle; P J Meunier; R Dusan; M Guillaume; J L Martin; A Gaucher; A Prost; G Zeigler; P Netter
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

9.  Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D.

Authors:  C Hasling; H E Nielsen; F Melsen; L Mosekilde
Journal:  Miner Electrolyte Metab       Date:  1987

10.  Trabecular stress fractures during fluoride therapy for osteoporosis.

Authors:  C M Schnitzler; L Solomon
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.